This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Pamnani, M. B. Articles by Cragoe, E. J. Search for Related Content PubMed PubMed Citation Articles by Pamnani, M. B. Articles by Cragoe, E. J., Jr

Hypertension, Vol 11, 445-451, Copyright © 1988 by American Heart Association

ARTICLES

Effect of 6-iodoamiloride in various models of experimental hypertension

MB Pamnani, MS Rinaudo, FJ Haddy and EJ Cragoe Jr
Department of Physiology, Uniformed Services University, Bethesda, Maryland 20814-4799.

6-Iodoamiloride, an analogue of the sodium channel blocker amiloride, is a vasodilator-depressor, diuretic-natriuretic, and antikaliuretic agent. In these experiments we intravenously infused 6-iodamiloride (0.38 mg/100 g body weight) over a 10- to 11-minute period into rats with reduced renal mass-saline hypertension or one-kidney, one clip hypertension. The infusion produced a prompt but transient fall in blood pressure. These findings are in contrast to those in spontaneously hypertensive rats (SHR), in which the same infusion of 6- iodoamiloride produced a prompt, pronounced, and sustained fall in blood pressure. Studies from a number of laboratories suggest that vascular smooth muscle cells from the SHR have increased permeability to sodium whereas vascular smooth muscle cells from the other two models do not. Thus, 6-iodoamiloride may have potential both as a diagnostic probe and a therapeutic agent for hypertension characterized by increased vascular smooth muscle cell permeability to sodium.